Clinical Trial Update: EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial [Phase 4]

View source ↗

Summary

The Phase 4 pragmatic trial evaluating EMI-EHP weight management for Type 2 diabetes mellitus and obesity was terminated, with results posted on 2024-07-22.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The Cleveland Clinic | Conditions: Type 2 Diabetes, Obesity | Phase 4 | Status: TERMINATED | Results posted: 2024-07-22